Your browser doesn't support javascript.
loading
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways.
López-Isac, Elena; Acosta-Herrera, Marialbert; Kerick, Martin; Assassi, Shervin; Satpathy, Ansuman T; Granja, Jeffrey; Mumbach, Maxwell R; Beretta, Lorenzo; Simeón, Carmen P; Carreira, Patricia; Ortego-Centeno, Norberto; Castellvi, Ivan; Bossini-Castillo, Lara; Carmona, F David; Orozco, Gisela; Hunzelmann, Nicolas; Distler, Jörg H W; Franke, Andre; Lunardi, Claudio; Moroncini, Gianluca; Gabrielli, Armando; de Vries-Bouwstra, Jeska; Wijmenga, Cisca; Koeleman, Bobby P C; Nordin, Annika; Padyukov, Leonid; Hoffmann-Vold, Anna-Maria; Lie, Benedicte; Proudman, Susanna; Stevens, Wendy; Nikpour, Mandana; Vyse, Timothy; Herrick, Ariane L; Worthington, Jane; Denton, Christopher P; Allanore, Yannick; Brown, Matthew A; Radstake, Timothy R D J; Fonseca, Carmen; Chang, Howard Y; Mayes, Maureen D; Martin, Javier.
Afiliación
  • López-Isac E; Institute of Parasitology and Biomedicine López-Neyra, IPBLN-CSIC, Granada, Spain. eisac.csic@gmail.com.
  • Acosta-Herrera M; Institute of Parasitology and Biomedicine López-Neyra, IPBLN-CSIC, Granada, Spain.
  • Kerick M; Institute of Parasitology and Biomedicine López-Neyra, IPBLN-CSIC, Granada, Spain.
  • Assassi S; The University of Texas Health Science Center-Houston, Houston, USA.
  • Satpathy AT; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA.
  • Granja J; Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA.
  • Mumbach MR; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA.
  • Beretta L; Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA.
  • Simeón CP; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA.
  • Carreira P; Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA.
  • Ortego-Centeno N; Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
  • Castellvi I; Department of Internal Medicine, Valle de Hebrón Hospital, Barcelona, Spain.
  • Bossini-Castillo L; Department of Rheumatology, 12 de Octubre University Hospital, Madrid, Spain.
  • Carmona FD; Department of Internal Medicine, San Cecilio Clinic University Hospital, Granada, Spain.
  • Orozco G; Department of Rheumatology, Santa Creu i Sant Pau University Hospital, Barcelona, Spain.
  • Hunzelmann N; Wellcome Trust Sanger Institute, Hinxton, UK.
  • Distler JHW; Department of Genetics and Institute of Biotechnology, University of Granada, Granada, Spain.
  • Franke A; Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Oxford Road, Manchester, UK.
  • Lunardi C; Department of Dermatology, University of Cologne, Cologne, Germany.
  • Moroncini G; Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Gabrielli A; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
  • de Vries-Bouwstra J; Department of Medicine, Università degli Studi di Verona, Verona, Italy.
  • Wijmenga C; Clinica Medica, Department of Clinical and Molecular Science, Università Politecnica delle Marche and Ospedali Riuniti, Ancona, Italy.
  • Koeleman BPC; Clinica Medica, Department of Clinical and Molecular Science, Università Politecnica delle Marche and Ospedali Riuniti, Ancona, Italy.
  • Nordin A; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
  • Padyukov L; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  • Hoffmann-Vold AM; University Medical Center Utrecht, Utrecht, The Netherlands.
  • Lie B; Division of Rheumatology, Department of Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden.
  • Proudman S; Department of Rheumatology, Oslo University Hospital, Oslo, Norway.
  • Stevens W; Department of Medical Genetics, and the Department of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway.
  • Vyse T; St. Vincent's Hospital, Melbourne, VIC, Australia.
  • Herrick AL; The University of Melbourne at St. Vincent's Hospital, Melbourne, VIC, Australia.
  • Denton CP; Department of Medical and Molecular Genetics, King's College London, London, UK.
  • Allanore Y; Centre for Musculoskeletal Research, The University of Manchester, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Brown MA; NIHR Manchester Biomedical Research Centre, Manchester, UK.
  • Radstake TRDJ; Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Oxford Road, Manchester, UK.
  • Fonseca C; Centre for Rheumatology, Royal Free and University College Medical School, London, United Kingdom.
  • Chang HY; Department of Rheumatology A, Cochin Hospital, INSERM U1016, Paris Descartes University, Paris, France.
  • Mayes MD; Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Martin J; Department of Rheumatology & Clinical Immunology, Laboratory of Translational Immunology, department of Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
Nat Commun ; 10(1): 4955, 2019 10 31.
Article en En | MEDLINE | ID: mdl-31672989
ABSTRACT
Systemic sclerosis (SSc) is an autoimmune disease that shows one of the highest mortality rates among rheumatic diseases. We perform a large genome-wide association study (GWAS), and meta-analysis with previous GWASs, in 26,679 individuals and identify 27 independent genome-wide associated signals, including 13 new risk loci. The novel associations nearly double the number of genome-wide hits reported for SSc thus far. We define 95% credible sets of less than 5 likely causal variants in 12 loci. Additionally, we identify specific SSc subtype-associated signals. Functional analysis of high-priority variants shows the potential function of SSc signals, with the identification of 43 robust target genes through HiChIP. Our results point towards molecular pathways potentially involved in vasculopathy and fibrosis, two main hallmarks in SSc, and highlight the spectrum of critical cell types for the disease. This work supports a better understanding of the genetic basis of SSc and provides directions for future functional experiments.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Vasculares / Fibrosis Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2019 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Vasculares / Fibrosis Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2019 Tipo del documento: Article País de afiliación: España
...